Clinical Trials Browser

Interventional × Exanthema × Thoracic × Clear all

NCT01880515 2025-05-11

Tetracycline as a Prophylaxis for Rash in Patients With NSCLC Receiving Treatment With BIBW2992 (Afatinib)

Phase 2 Completed

107 enrolled 8 charts

Exanthema, Lung Neoplasms

NCT03992664 2025-02-13

Education Intervention in Patients with Rash Due to Epidermal Growth Factor Receptor (EGFR) Treatment.

Phase NA Completed

BreastGastrointestinalHead & NeckThoracic

Breast Neoplasms, Colonic Neoplasms, Exanthema, Head and Neck Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Photosensitivity Disorders, Pruritus

NCT04878692 2021-05-07

OPERA

Phase NA Unknown

GastrointestinalHead & NeckThoracic

Acne Vulgaris, Carcinoma, Non-Small-Cell Lung, Exanthema, Head and Neck Neoplasms, Colorectal Neoplasms

NCT00473083 2017-04-04

LUTRAERL

Phase 2 Completed

150 enrolled 13 charts

Exanthema, Lung Neoplasms

NCT00803842 2015-02-26

Erlotinib Pharmacokinetics During Doxycycline Treatment for Erlotinib-induced Rash

Phase NA Withdrawn

Carcinoma, Non-Small-Cell Lung, Exanthema

NCT00343187 2011-05-30

A Phase II Study of ACZONE™ (Dapsone) Gel, 5% As a Treatment For Tarceva® (Erlotinib)Related Rash

Phase 2 Terminated

Carcinoma, Non-Small-Cell Lung, Exanthema

NCT00158041 2005-09-12

Subcutaneous Amifostine Safety Study

Phase 4 Completed

Head & NeckLymphoidOtherThoracic

Exanthema, Head and Neck Neoplasms, Hypotension, Lung Neoplasms, Lymphoma, Nausea, Mucositis